Is Roivant Sciences Ltd (NASDAQ: ROIV) Back In The Buying Zone?

Currently, there are 760.14M common shares owned by the public and among those 478.44M shares have been available to trade.

However, the script later moved the day high at 10.90, up 0.56%. The company’s stock has a 5-day price change of 8.48% and 27.13% over the past three months. ROIV shares are trading -3.21% year to date (YTD), with the 12-month market performance up to 40.08% higher. It has a 12-month low price of $6.59 and touched a high of $13.24 over the same period. ROIV has an average intraday trading volume of 1.27 shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.42%, 3.03%, and 6.01% respectively.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


Institutional ownership of Roivant Sciences Ltd (NASDAQ: ROIV) shares accounts for 56.43% of the company’s 760.14M shares outstanding.

It has a market capitalization of $8.74B and a beta (3y monthly) value of 1.35. The earnings-per-share (ttm) stands at -$1.32. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.97% over the week and 3.30% over the month.

Analysts forecast that Roivant Sciences Ltd (ROIV) will achieve an EPS of $RiskOn International, Inc. for the current quarter, $0.11 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $RiverNorth Opportunities Fund, while analysts give the company a high EPS estimate of $Retail Opportunity Investments . Comparatively, EPS for the current quarter was $RDIV a year ago. Earnings per share for the fiscal year are expected to decrease by -12.52%, and 15.64% over the next financial year.

Looking at the support for the ROIV, a number of firms have released research notes about the stock. Piper Sandler stated their Overweight rating for the stock in a research note on January 05, 2024, with the firm’s price target at $20.

Most Popular

Related Posts